These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8029859)

  • 1. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
    Thomas FT; Pittman K; Brezina P; Wu J; Mountz J; Contreras J; Thomas J
    Transplant Proc; 1997; 29(1-2):760-1. PubMed ID: 9123513
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful long-term pancreatic islet cell xenotransplantation and functional tolerance in NOD mice.
    Ljung T; Pittman K; Thomas FT
    Transplant Proc; 1995 Feb; 27(1):1351-2. PubMed ID: 7878908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts.
    Henretta J; Pittman K; McFadden T; Thomas J; Thomas F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):412-3. PubMed ID: 8438358
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of functional xenograft tolerance of pig islets in the autoimmune NOD mouse.
    Thomas FT; Pittman K; Thomas JM
    Transplant Proc; 1995 Dec; 27(6):3323-5. PubMed ID: 8539973
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction in primary nonfunction of pancreas islet transplants with antithymocyte globulin agents, deoxyspergualin, and splenectomy.
    Pittman K; Thomas F; McFadden T; Haisch C; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):986-7. PubMed ID: 8442292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of xenograft resistance to autoimmune disease recurrence after pancreas islet transplantation.
    Thomas F; Pittman K; Larkin E; Berzina P; Contreras J; Quarantillo P; Thomas J
    Transplant Proc; 1999; 31(1-2):964-5. PubMed ID: 10083429
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
    Hisanaga M; Nakajima Y; Yabuuchi H; Nakano H
    Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of discordant islet xenografts for the treatment of type II diabetes.
    Pittman K; Henretta J; Thomas J; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1135-7. PubMed ID: 8029860
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of primary nonfunction of xenograft islets.
    Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT
    Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of primary nonfunction in discordant pancreas islet xenografts.
    Pittman K; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):649-50. PubMed ID: 1566465
    [No Abstract]   [Full Text] [Related]  

  • 12. Microencapsulated islets in agarose gel as bioartificial pancreas for discordant xenotransplantation.
    Aomatsu Y; Iwata H; Takagi T; Amemiya H; Nakajima Y; Kanehiro H; Hisanaga M; Fukuoka T; Nakano H
    Transplant Proc; 1992 Dec; 24(6):2922-3. PubMed ID: 1466001
    [No Abstract]   [Full Text] [Related]  

  • 13. Pig-to-human islet transplantation in eight patients.
    Tibell A; Groth CG; Möller E; Korsgren O; Andersson A; Hellerström C
    Transplant Proc; 1994 Apr; 26(2):762-3. PubMed ID: 8171652
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of primary nonfunction after porcine islet allotransplantation.
    Liu X; Hering BJ; Mellert J; Brandhorst D; Brandhorst H; Federlin K; Bretzel RG; Hopt UT
    Transplant Proc; 1997 Jun; 29(4):2071-2. PubMed ID: 9193532
    [No Abstract]   [Full Text] [Related]  

  • 15. Fish-to-mouse islet xenograft survival is markedly prolonged by 15-deoxyspergualin.
    Wright JR; Kearns H
    Transplant Proc; 1995 Feb; 27(1):294-5. PubMed ID: 7879009
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenotransplantation of islets of Langerhans in diabetes mellitus.
    Mandel TE; Koulmanda M
    Transplant Proc; 1994 Jun; 26(3):1110-2. PubMed ID: 8029849
    [No Abstract]   [Full Text] [Related]  

  • 17. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression.
    Henretta J; McFadden T; Pittman K; Thomas J; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1138-9. PubMed ID: 8029861
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation.
    Aomatsu Y; Nakajima Y; Iwata H; Amemiya H; Kanehiro H; Hisanaga M; Yoshimura A; Kido K; Taki J; Horikawa M
    Transplant Proc; 1995 Feb; 27(1):292-3. PubMed ID: 7879008
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 15-deoxyspergualin in islet xenograft rejection.
    Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
    Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.